Status:
COMPLETED
Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Charite University, Berlin, Germany
Conditions:
Amenorrhea
Hot Flashes
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Breast cancer survivors often suffer from climacteric symptoms caused by treatment or diagnosis of their disease. Hormone replacement therapy is contraindicated and other pharmacological options may ...
Detailed Description
Patients should use 2-5 different treatment options per day and fulfill a diary for symptoms and adherence to self-treatment for 12 weeks.
Eligibility Criteria
Inclusion
- Breast cancer diagnosis
- Menopausal complaints score \> 14 (MRS II)
- End of last chemotherapy or radiotherapy \> 2 months
- Expected stable disease for the next 6 months
Exclusion
- Regular intake of glucocorticoids
- Regular practice of hydrotherapy before inclusion
- Start or change of other treatments/changes of lifestyle in order to influence menopausal symptoms
- Psychiatric disorders with possible influence on compliance and adherence to the protocol
- Other severe or progressive diseases with influence on compliance and adherence to the protocol
- Contraindications to hydrotherapy (severe heart failure, relevant dermatological diseases, Raynaud's Phenomenon \[M. Raynaud\], peripheral arterial occlusive disease Fontaine stage IIb \[VK IIb\] or more, acute thrombosis, or thrombophlebitis)
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00243607
Start Date
May 1 2006
End Date
October 1 2008
Last Update
May 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ambulanz für Naturheilkunde und Integrative Medizin
Heidelberg, Baden-Wurttemberg, Germany, D-69115